AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19931157 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 248
Study 18243335 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 56
Study 18243335 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 56
Study 18243335 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 56
Study 18243335 — intervention group
Group type: COMPARATOR
Intervention: Control (healthy volunteers)
Number of subjects: 56
Study 18243335 — intervention group
Group type: EXPERIMENTAL
Intervention: All antipsychotic treatments
Number of subjects: 56
Study 16012274 — intervention group
Group type: EXPERIMENTAL
Intervention: Nocturnal intravenous TRH 500 microg
Number of subjects: 20
Study 16012274 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 20
Study 12887812 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactulose (15 - 90 ml/day) for 8 weeks in Stg
Number of subjects: 64
Study 12887812 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactulose (15 - 90 ml/day) for 24 weeks in Ltg
Number of subjects: 64
Study 12887812 — intervention group
Group type: COMPARATOR
Intervention: Control group (Cg) with no lactulose treatment
Number of subjects: 64
Study 12887812 — intervention group
Group type: COMPARATOR
Intervention: Control group (Cg)
Number of subjects: 64
Study 11232539 — intervention group
Group type: EXPERIMENTAL
Intervention: More elaborate encoding task
Number of subjects: 0
Study 11232539 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 8653868 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukocyte-depleted terminal blood cardioplegia (LDTC)
Number of subjects: 30
Study 8653868 — intervention group
Group type: COMPARATOR
Intervention: Terminal blood cardioplegia (TC)
Number of subjects: 30
Study 8653868 — intervention group
Group type: COMPARATOR
Intervention: Whole blood (WB)
Number of subjects: 30
Study 1455377 — intervention group
Group type: EXPERIMENTAL
Intervention: Chondroprotective therapy; specific drugs not mentioned; details on dosage and duration not available.
Number of subjects: 0
Study 1455377 — intervention group
Group type: COMPARATOR
Intervention: Chondroprotective drugs; specific drugs not mentioned; details on dosage and duration not available.
Number of subjects: 0
Study 3877900 — intervention group
Group type: EXPERIMENTAL
Intervention: High and low frequency transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 50
Study 3877900 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical vibratory stimulation at 100 Hz
Number of subjects: 50
Study 3877900 — intervention group
Group type: COMPARATOR
Intervention: Placebo stimulation
Number of subjects: 50
Study 31470759 — intervention group
Group type: EXPERIMENTAL
Intervention: ADRC
Number of subjects: 39
Study 31470759 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 39
Study 29564661 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonographic evaluation by medical students after training
Number of subjects: 10
Study 29564661 — intervention group
Group type: COMPARATOR
Intervention: Gold standard evaluation by an experienced consultant
Number of subjects: 10
Study 29564661 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitions of the sonographic task
Number of subjects: 10
Study 26433782 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg of cadazolid twice daily for 10 days
Number of subjects: 84
Study 26433782 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg of cadazolid twice daily for 10 days
Number of subjects: 84
Study 26433782 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg of cadazolid twice daily for 10 days
Number of subjects: 84
Study 26433782 — intervention group
Group type: COMPARATOR
Intervention: 125 mg of vancomycin four times daily for 10 days
Number of subjects: 84
Study 26433782 — intervention group
Group type: EXPERIMENTAL
Intervention: All cadazolid doses
Number of subjects: 84
Study 26433782 — intervention group
Group type: EXPERIMENTAL
Intervention: All C. difficile isolates
Number of subjects: 84
Study 24178631 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face interview (FFI)
Number of subjects: 0
Study 24178631 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone interview (TI)
Number of subjects: 0
Study 22930737 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-varying magnetic fields (TVMF) within a static magnetic stray field (SMF) of a 7 Tesla MRI scanner
Number of subjects: 31
Study 22930737 — intervention group
Group type: COMPARATOR
Intervention: Sham (0 T) exposure
Number of subjects: 31
Study 22930737 — intervention group
Group type: COMPARATOR
Intervention: Low (0.5 T) SMF exposure
Number of subjects: 31
Study 22930737 — intervention group
Group type: COMPARATOR
Intervention: High (1.0 T) SMF exposure
Number of subjects: 31
Study 20633254 — intervention group
Group type: EXPERIMENTAL
Intervention: Living alone and being a smoker or ex-smoker
Number of subjects: 651
Study 20633254 — intervention group
Group type: COMPARATOR
Intervention: Socioeconomic status (social class, educational level, municipality family income)
Number of subjects: 651
Study 18327363 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac 100 mg
Number of subjects: 75
Study 18327363 — intervention group
Group type: EXPERIMENTAL
Intervention: Meloxicam 15 mg
Number of subjects: 75
Study 18327363 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 15955470 — intervention group
Group type: EXPERIMENTAL
Intervention: Subtotal fasting (< 300 kcal/day, only from carbohydrates)
Number of subjects: 20
Study 15955470 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study 12463616 — intervention group
Group type: EXPERIMENTAL
Intervention: Below-knee, Scholl, Flight Socks (14-17 mm Hg pressure at the ankle)
Number of subjects: 657
Study 12463616 — intervention group
Group type: COMPARATOR
Intervention: Control group (no prophylaxis)
Number of subjects: 657
Study 10726353 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoladex (GnRH agonist)
Number of subjects: 34
Study 10726353 — intervention group
Group type: COMPARATOR
Intervention: Control group (without medication)
Number of subjects: 34
Study 7562288 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin prophylaxis (100 mg/kg per day)
Number of subjects: 75
Study 7562288 — intervention group
Group type: COMPARATOR
Intervention: Control (no prophylactic antibiotic treatment)
Number of subjects: 75
Study 7562288 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin prophylaxis
Number of subjects: 75
Study 7562288 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 75
Study 2265368 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin (20 mg IV followed by infusion of 20 mg in 400 ml of 5% glucose)
Number of subjects: 10
Study 2265368 — intervention group
Group type: COMPARATOR
Intervention: Placebo (400 ml of 5% glucose)
Number of subjects: 10
Study 7005459 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-day course of doxycycline therapy
Number of subjects: 105
Study 7005459 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-day course of doxycycline therapy
Number of subjects: 105
Study 30670270 — intervention group
Group type: EXPERIMENTAL
Intervention: Bikram yoga intervention (3-5 classes weekly for 16 weeks)
Number of subjects: 29
Study 28105705 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride varnish (Duraphat) with fluoride toothpaste
Number of subjects: 15
Study 28105705 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride varnish (Profluorid Varnish) with fluoride toothpaste
Number of subjects: 15
Study 28105705 — intervention group
Group type: COMPARATOR
Intervention: Fluoride varnish (Duraphat) without fluoride toothpaste
Number of subjects: 15
Study 28105705 — intervention group
Group type: COMPARATOR
Intervention: Fluoride varnish (Profluorid Varnish) without fluoride toothpaste
Number of subjects: 15
Study 26306400 — intervention group
Group type: EXPERIMENTAL
Intervention: Hexanic Extract of Serenoa repens (HESr) 320mg
Number of subjects: 206
Study 26306400 — intervention group
Group type: COMPARATOR
Intervention: Tamsulosin 0.4mg
Number of subjects: 206
Study 23260452 — intervention group
Group type: EXPERIMENTAL
Intervention: Heterotopic noxious counter-stimulation (HNCS) with a flexible cold pack applied on the contralateral forearm.
Number of subjects: 0
Study 23260452 — intervention group
Group type: COMPARATOR
Intervention: Suggestions of hyperalgesia.
Number of subjects: 0
Study 23260452 — intervention group
Group type: EXPERIMENTAL
Intervention: Suggestions of analgesia.
Number of subjects: 0
Study 23260452 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in shock-anxiety due to suggestions.
Number of subjects: 0
Study 21681079 — intervention group
Group type: EXPERIMENTAL
Intervention: Aloe vera mouthwash
Number of subjects: 46
Study 21681079 — intervention group
Group type: COMPARATOR
Intervention: Triamcinolone acetonide 0.1%
Number of subjects: 46
Study 18844015 — intervention group
Group type: EXPERIMENTAL
Intervention: NeoSoniX handpiece
Number of subjects: 659
Study 18844015 — intervention group
Group type: COMPARATOR
Intervention: Standard handpiece
Number of subjects: 659
Study 18690916 — intervention group
Group type: COMPARATOR
Intervention: Benzodiazepine hypnotics (recommended dose)
Number of subjects: 207
Study 18690916 — intervention group
Group type: COMPARATOR
Intervention: Benzodiazepine hypnotics (twice the recommended dose)
Number of subjects: 207
Study 18690916 — intervention group
Group type: COMPARATOR
Intervention: Zopiclone 7.5 mg
Number of subjects: 207
Study 18690916 — intervention group
Group type: COMPARATOR
Intervention: Zolpidem 10 mg
Number of subjects: 207
Study 18690916 — intervention group
Group type: COMPARATOR
Intervention: Zolpidem 20 mg
Number of subjects: 207
Study 18690916 — intervention group
Group type: COMPARATOR
Intervention: Zaleplon (10 and 20 mg)
Number of subjects: 207
Study 14680731 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term enoxaparin 1 mg/kg subcutaneously twice a day
Number of subjects: 6098
Study 14680731 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term unfractionated heparin (UFH)
Number of subjects: 6098
Study 14680731 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuation of a fixed-dose enoxaparin 60 mg subcutaneously twice a day
Number of subjects: 6098
Study 11093970 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam
Number of subjects: 82
Study 11093970 — intervention group
Group type: COMPARATOR
Intervention: Control (healthy controls)
Number of subjects: 82
Study 9306168 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated Auditory Brainstem Response (ABR)
Number of subjects: 200
Study 9306168 — intervention group
Group type: COMPARATOR
Intervention: Click Evoked Otoacoustic Emissions (EOAE)
Number of subjects: 200
Study 8124120 — intervention group
Group type: EXPERIMENTAL
Intervention: Health checks by nurses (intervention group)
Number of subjects: 6124
Study 2768695 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4% stannous fluoride (SnF2)
Number of subjects: 281
Study 2768695 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.22% sodium fluoride (NaF)
Number of subjects: 281
Study 2768695 — intervention group
Group type: COMPARATOR
Intervention: Fluoride-free placebo gel
Number of subjects: 281
Study 336178 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide (Cytoxan), regimen A
Number of subjects: 417
Study 336178 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide alternating with methotrexate, regimen B
Number of subjects: 417
Study 336178 — intervention group
Group type: COMPARATOR
Intervention: No additional therapy (control)
Number of subjects: 417
Study 31689588 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 Hz rTMS over SMA (N=20)
Number of subjects: 30
Study 31689588 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS (N=10)
Number of subjects: 30
Study 29275373 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 438
Study 29275373 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 438
Study 29275373 — intervention group
Group type: COMPARATOR
Intervention: No insulin
Number of subjects: 438
Study 29275373 — intervention group
Group type: COMPARATOR
Intervention: No metformin
Number of subjects: 438
Study 29275373 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment arms
Number of subjects: 438
Study 25975659 — intervention group
Group type: EXPERIMENTAL
Intervention: Uninterrupted rivaroxaban (20 mg once-daily)
Number of subjects: 248
Study 24219882 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone therapy (transdermal estradiol 1 mg/d, oral estradiol 2 mg/d with or without medroxyprogesterone acetate 5 mg/d)
Number of subjects: 150
Study 24219882 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 23006063 — intervention group
Group type: EXPERIMENTAL
Intervention: Profiling group (dialysate temperature 35.5°C, variable sodium concentration [150-138 mEq/L], variable UF rate)
Number of subjects: 31
Study 23006063 — intervention group
Group type: COMPARATOR
Intervention: Control group (dialysate temperature 37.0°C, fixed sodium concentration [138 mEq/L], fixed UF rate)
Number of subjects: 31
Study 23006063 — intervention group
Group type: EXPERIMENTAL
Intervention: Profiling group
Number of subjects: 31
Study 23006063 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 31
Study 19531961 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifactorial continued educational and behavioral intervention for 2 years
Number of subjects: 52
Study 19531961 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 52
Study 17401691 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived access to recreational facilities
Number of subjects: 1367
Study 17401691 — intervention group
Group type: EXPERIMENTAL
Intervention: Basketball courts within a mile of homes
Number of subjects: 1367
Study 17401691 — intervention group
Group type: EXPERIMENTAL
Intervention: Total number of facilities perceived
Number of subjects: 1367
Study 17401691 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of facilities within a half-mile of girls' homes
Number of subjects: 1367
Study 17401691 — intervention group
Group type: COMPARATOR
Intervention: Objective facility measures
Number of subjects: 1367
Study 15249978 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical test confirming blindness certificates
Number of subjects: 117
Study 15249978 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical test grading
Number of subjects: 117
Study 15249978 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of certificates and medical test results
Number of subjects: 117
Study 11442161 — intervention group
Group type: EXPERIMENTAL
Intervention: SCP self-regulation
Number of subjects: 0
Study 11442161 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication with new anticonvulsive drugs (AEDs) and psychosocial counseling (MED group)
Number of subjects: 0
Study 11442161 — intervention group
Group type: COMPARATOR
Intervention: Self-control of respiratory parameters (RES group)
Number of subjects: 0
Study 9169364 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprotinin 1 million KIU
Number of subjects: 52
Study 9169364 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 1531742 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine sulfate (group M, n = 54, up to 2 mg/kg)
Number of subjects: 106
Study 1531742 — intervention group
Group type: COMPARATOR
Intervention: Sufentanil (group S, n = 52, 1 microgram/kg and 1 microgram.kg-1.h-1)
Number of subjects: 106
Study 1531742 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil (group S)
Number of subjects: 106
Study 1531742 — intervention group
Group type: COMPARATOR
Intervention: Morphine sulfate (group M)
Number of subjects: 106
Study 1531742 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 106
Study 3956454 — intervention group
Group type: EXPERIMENTAL
Intervention: Eterobarb
Number of subjects: 0
Study 3956454 — intervention group
Group type: COMPARATOR
Intervention: Phenobarbital
Number of subjects: 0
Study 3956454 — intervention group
Group type: EXPERIMENTAL
Intervention: Eterobarb and Phenobarbital
Number of subjects: 0
Study 30322793 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided mindfulness-based meditation (GM)
Number of subjects: 76
Study 30322793 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused breathing (FB)
Number of subjects: 76
Study 30322793 — intervention group
Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 76
Study 29611221 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally rough implants (Turned surface - Tur)
Number of subjects: 18
Study 29611221 — intervention group
Group type: COMPARATOR
Intervention: Moderately rough implants (TiUnite surface - TiU)
Number of subjects: 18
Study 27438431 — intervention group
Group type: EXPERIMENTAL
Intervention: Allergy intervention (structured allergy history, skin prick testing, and appropriate allergy avoidance advice)
Number of subjects: 335
Study 27438431 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 335
Study 24752682 — intervention group
Group type: EXPERIMENTAL
Intervention: Primaquine 0.5 mg/kg per day for 5 days (150 mg total)
Number of subjects: 540
Study 24752682 — intervention group
Group type: EXPERIMENTAL
Intervention: Primaquine 0.5 mg/kg per day for 7 days (210 mg total)
Number of subjects: 540
Study 24752682 — intervention group
Group type: EXPERIMENTAL
Intervention: Primaquine 0.25 mg/kg per day for 14 days (210 mg total)
Number of subjects: 540
Study 21592596 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Pain Management Program (IPMP)
Number of subjects: 147
Study 19912315 — intervention group
Group type: EXPERIMENTAL
Intervention: Home orthostatic training (HOT)
Number of subjects: 38
Study 19912315 — intervention group
Group type: COMPARATOR
Intervention: Sham training
Number of subjects: 38
Study 17351280 — intervention group
Group type: EXPERIMENTAL
Intervention: Ephedrine HCl (25 mg, 3 times daily) plus caffeine (200 mg, 3 times daily)
Number of subjects: 57
Study 17351280 — intervention group
Group type: EXPERIMENTAL
Intervention: Ephedrine plus caffeine/pioglitazone (ECPio)
Number of subjects: 57
Study 17351280 — intervention group
Group type: COMPARATOR
Intervention: Placebo/pioglitazone (PPio)
Number of subjects: 57
Study 17351280 — intervention group
Group type: COMPARATOR
Intervention: Placebo/placebo (PP)
Number of subjects: 57
Study 16324168 — intervention group
Group type: EXPERIMENTAL
Intervention: Noise (50 dB of white noise)
Number of subjects: 68
Study 16324168 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative affect (stressor challenge with difficult-to-solve anagrams and failure feedback)
Number of subjects: 68
Study 16324168 — intervention group
Group type: COMPARATOR
Intervention: Control (absence of both noise and negative affect)
Number of subjects: 68
Study 11987055 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine
Number of subjects: 64
Study 11987055 — intervention group
Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 64
Study 11987055 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 64
Study 9854329 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil combined with propofol (group 1: 100 micrograms/kg/min; n = 7)
Number of subjects: 23
Study 9854329 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil combined with enflurane (group 2: 0.5 MAC; n = 8)
Number of subjects: 23
Study 9854329 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil combined with isoflurane (group 3: 0.5 MAC; n = 8)
Number of subjects: 23
Study 9854329 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil (0.5 microgram/kg/min) during surgery
Number of subjects: 23
Study 7608645 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy (HRT)
Number of subjects: 76
Study 7608645 — intervention group
Group type: COMPARATOR
Intervention: Dietary therapy (Control)
Number of subjects: 76
Study 2405804 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg daily
Number of subjects: 251
Study 2405804 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg daily
Number of subjects: 251
Study 2405804 — intervention group
Group type: COMPARATOR
Intervention: Cholestyramine resin 4 to 12 g twice daily
Number of subjects: 251
Study 2405804 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 251
Study 2405804 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 251
Study 2405804 — intervention group
Group type: COMPARATOR
Intervention: Cholestyramine
Number of subjects: 251
Study 7357822 — intervention group
Group type: EXPERIMENTAL
Intervention: Elemental diet supplementation
Number of subjects: 0
Study 7357822 — intervention group
Group type: COMPARATOR
Intervention: Standard low‐roughage diet
Number of subjects: 0
Study 30920620 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole (2.5 mg/d) for 2 weeks
Number of subjects: 22
Study 30920620 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen (20 mg/d) for 2 weeks
Number of subjects: 22
Study 28036410 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 exposures of interactive book reading
Number of subjects: 27
Study 28036410 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 exposures of interactive book reading
Number of subjects: 27
Study 28036410 — intervention group
Group type: EXPERIMENTAL
Intervention: 36 exposures of interactive book reading
Number of subjects: 27
Study 28036410 — intervention group
Group type: EXPERIMENTAL
Intervention: 48 exposures of interactive book reading
Number of subjects: 27
Study 28036410 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive book reading
Number of subjects: 27
Study 28036410 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with poor phonological awareness, low vocabulary, and/or poor nonword repetition
Number of subjects: 27
Study 25938213 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-cm FOV
Number of subjects: 29
Study 25938213 — intervention group
Group type: EXPERIMENTAL
Intervention: 15-cm FOV
Number of subjects: 29
Study 25938213 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-cm FOV
Number of subjects: 29
Study 25938213 — intervention group
Group type: EXPERIMENTAL
Intervention: Human airway measurements
Number of subjects: 29
Study 25938213 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction from 30 to 15 cm
Number of subjects: 29
Study 23360819 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week low-energy diet
Number of subjects: 0